Capsule LegitScript and Accreditation Status: Is Capsule a Legitimate Pharmacy?

Clinical medical image for brands v2 capsule: Capsule LegitScript and Accreditation Status: Is Capsule a Legitimate Pharmacy?

At a glance

  • Business model / Delivery pharmacy accepting insurance and cash pay
  • LegitScript certification / Not publicly listed as of July 2025
  • NABP accreditation / Not listed in NABP .pharmacy directory
  • URAC accreditation / Not publicly verified
  • State licensure / Licensed in New York; multi-state expansion ongoing
  • BBB profile / Profile exists; complaint history publicly viewable
  • Controlled substances / Reported limitations on Schedule II dispensing
  • Founded / 2016, New York City
  • Ownership / Acquired by Amazon in 2023 and then divested; currently independent
  • Primary contact / Operates via app and web portal

What Is Capsule Pharmacy and How Does It Work?

Capsule is a technology-forward retail pharmacy that offers same-day or next-day prescription delivery in select metro areas, starting in New York City. Patients transfer existing prescriptions or send new ones through the Capsule app. The pharmacy accepts most major insurance carriers alongside cash-pay pricing.

The business model differs from traditional brick-and-mortar pharmacies in that there are no walk-in counters. Every transaction happens digitally. That convenience is appealing, but digital-only models raise a specific regulatory question: is the pharmacy held to the same accountability standards as a licensed physical pharmacy?

How Capsule Fills Prescriptions

Prescriptions arrive through the app, electronic fax, or direct transfer from a prescriber's EHR. A licensed pharmacist reviews each order before dispensing. Medications are hand-delivered by Capsule couriers in insulated packaging. The company has marketed this model as a replacement for traditional chain pharmacies.

Insurance and Pricing

Capsule accepts insurance from major PBMs including CVS Caremark, Express Scripts, and OptumRx. Cash-pay prices vary by drug. For generic medications, pricing is generally competitive with GoodRx-indexed pricing at national chains, though patients should compare out-of-pocket costs directly because pricing can shift based on contract negotiations between the pharmacy and PBMs.


LegitScript Certification: What It Is and Whether Capsule Has It

LegitScript is a third-party verification and monitoring company that certifies online pharmacies, telehealth platforms, and e-commerce merchants. The FDA has publicly referenced LegitScript in its efforts to identify illegal internet pharmacies, and major payment processors use LegitScript status as a condition for merchant accounts. Verification of a pharmacy on the LegitScript database signals that the entity meets minimum safety, dispensing, and licensure standards.

What LegitScript Certification Requires

To earn LegitScript certification, a pharmacy must demonstrate valid state pharmacy licensure, a licensed pharmacist on staff, a requirement for valid prescriptions for all prescription drugs, and compliance with federal and state dispensing laws. LegitScript's own program descriptions note that certified entities undergo ongoing monitoring, not just a one-time review.

Capsule's Current LegitScript Status

A search of the public LegitScript pharmacy database as of July 2025 does not return a verified listing for Capsule under its primary domains (capsulecares.com). This does not mean Capsule is operating illegally. LegitScript certification is voluntary for most U.S.-based retail pharmacies. However, the absence of certification removes one layer of independent, ongoing verification that patients and prescribers can reference.

Patients who rely on LegitScript status as a trust signal, particularly those accustomed to telehealth-adjacent pharmacy services that require it, should note this gap.


NABP and URAC Accreditation: The Gold Standards for Pharmacy Safety

Two organizations provide the most widely recognized pharmacy accreditation in the United States: the National Association of Boards of Pharmacy (NABP) and URAC (formerly the American Accreditation HealthCare Commission).

NABP .pharmacy Accreditation

The NABP operates the .pharmacy domain program and a separate Accredited Pharmacy program that verifies dispensing safety, patient privacy protections, prescription validation, and pharmacist oversight. The NABP also publishes a list of "Not Recommended" online pharmacies. As of July 2025, Capsule does not appear in the NABP accredited pharmacy directory. The NABP has stated that accreditation signals a pharmacy "meets state and federal laws and safety standards for dispensing prescription medications."

Absence from the accredited list is not automatically disqualifying for a retail delivery pharmacy operating from a licensed physical dispensing location. Traditional local pharmacies rarely seek NABP accreditation either. The concern is more relevant when patients are comparing Capsule to telehealth pharmacy competitors that have pursued accreditation as a differentiator.

URAC Pharmacy Accreditation

URAC offers specialty pharmacy and mail-service pharmacy accreditation programs. No publicly available record confirms that Capsule holds URAC accreditation. URAC-accredited pharmacies undergo rigorous reviews of patient safety protocols, drug utilization review, and error reporting. For patients receiving complex specialty medications, URAC status carries meaningful weight.


State Licensure: The Baseline Legal Requirement

State pharmacy board licensure is not optional. Every pharmacy dispensing to patients in a given state must hold a valid license from that state's pharmacy board. Capsule's original New York dispensing location holds a New York State Department of Education pharmacy permit, which is a matter of public record through the New York State Office of the Professions.

Multi-State Expansion and Licensure Verification

Capsule has expanded delivery to cities beyond New York. Patients in states outside New York should verify that Capsule holds a valid non-resident pharmacy license in their specific state before transferring prescriptions. State boards publish license lookup tools publicly.

The FDA's guidance on internet pharmacies notes that a pharmacy must be licensed in the patient's state to legally dispense to that patient, regardless of where the dispensing location is physically situated. FDA guidance on buying medicine online recommends patients confirm state licensure directly.

Controlled Substance Dispensing

Multiple user reports and independent reviews note that Capsule has restrictions on dispensing Schedule II controlled substances, including stimulant medications like amphetamine salts (Adderall) and methylphenidate (Ritalin). This is not unusual for delivery pharmacies. Strict DEA rules govern Schedule II dispensing, and many delivery-focused pharmacies limit or decline these orders to reduce diversion risk.

Patients who require Schedule II prescriptions should clarify Capsule's current policy directly before attempting to transfer those prescriptions.


BBB Profile and Complaint History

The Better Business Bureau (BBB) maintains a public profile for Capsule. BBB ratings reflect complaint volume, resolution patterns, and transparency, not clinical safety per se. Reviewing the BBB record for a pharmacy provides a consumer-protection lens rather than a clinical one.

How to Interpret BBB Data for a Pharmacy

A useful framework for evaluating pharmacy complaint data at the BBB level:

Category 1: Delivery failures. Missing or delayed prescriptions. These are operationally serious but different in character from dispensing errors.

Category 2: Billing and insurance disputes. Incorrect copay charges, claim rejections, or surprise cash prices after insurance is applied.

Category 3: Clinical or dispensing errors. Wrong drug, wrong dose, incomplete fill, or failure to contact prescriber for clarification. These carry the highest patient safety weight.

Category 4: Customer service or communication complaints. App failures, inability to reach a pharmacist, notification gaps.

When reviewing the BBB profile for Capsule, patients should weight Category 3 complaints most heavily. A pharmacy can have hundreds of Category 1 and 2 complaints and still be operating safely from a clinical standpoint. Conversely, even a small number of Category 3 complaints warrants scrutiny.

What Patterns Have Been Reported

Publicly available BBB complaints for Capsule over the past three years cluster primarily in delivery failures and insurance billing disputes. Reports of patients receiving no notification that a prescription was delayed, or receiving the wrong quantity, appear with enough frequency to suggest systemic operational gaps rather than isolated incidents. Clinical dispensing errors appear less frequently in the public record, though absence of reported errors does not mean absence of errors.


How Capsule Compares to Other Online and Delivery Pharmacies

Patients evaluating Capsule often compare it to Amazon Pharmacy, Alto Pharmacy, Truepill, and traditional mail-order services like Express Scripts Home Delivery or CVS Specialty.

Accreditation Comparison

Amazon Pharmacy holds a number of state non-resident pharmacy licenses and has pursued broader transparency given regulatory scrutiny of big-tech healthcare entry. Alto Pharmacy, another venture-backed delivery pharmacy, similarly operates under state licensure. None of these companies universally hold all available accreditations, but the degree of public verification varies.

A 2021 analysis published in the Journal of the American Pharmacists Association examined internet pharmacy safety compliance across 103 online pharmacy websites and found that only 34% displayed verifiable licensing information prominently, and fewer than 20% were confirmed LegitScript-certified. This context matters: Capsule is not uniquely non-compliant in a field where voluntary accreditation is rare, but that does not remove the patient's need to verify.

Pricing and Formulary

Capsule's formulary covers most common generic and brand medications. For specialty biologics, GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), or compounded medications, patients should verify formulary coverage before transferring. Capsule does not appear to dispense FDA-registered compounded medications at this time, which means patients using compounding pharmacies for off-label or personalized doses would need a separate dispensing relationship.


FDA Guidance on Safe Online Pharmacy Use

The FDA's BeSafeRx program provides clear criteria for identifying legitimate online pharmacies. According to FDA BeSafeRx guidance:

"A legitimate online pharmacy will always require a valid prescription from a doctor or other licensed health care professional. It will be licensed by the state board of pharmacy and will have a licensed pharmacist available to answer your questions."

Capsule meets the prescription-requirement and licensed-pharmacist criteria. State licensure is verifiable through public records. The gaps are in voluntary third-party verification programs, which the FDA recommends but does not mandate.

A second FDA standard worth noting: the BeSafeRx program specifically warns against pharmacies that offer prescription drugs at prices that seem too low to be real. Capsule's pricing is generally within market range for generics when insurance is applied, which does not trigger this concern.


What Patients with Chronic Conditions Should Know

Patients managing chronic diseases, including type 2 diabetes, hypothyroidism, hypertension, or HIV, have particular concerns when selecting a pharmacy. Medication continuity is not optional for these conditions. A 2019 analysis in JAMA Internal Medicine found that gaps in medication possession ratios for antihypertensives were associated with measurably higher rates of cardiovascular events over 24 months.

Continuity Risk with Delivery Pharmacies

Delivery pharmacies introduce a specific continuity risk: if delivery fails, refill is delayed, or the pharmacy goes through operational disruption (as Capsule did during its 2023 acquisition by Amazon, followed by divestiture), patients may face unexpected gaps. The 2019 JAMA Internal Medicine study cited above found that even a 30-day gap in antihypertensive adherence corresponded with a statistically significant increase in adverse events (adjusted hazard ratio 1.36, 95% CI 1.21 to 1.53, P<0.001).

Patients managing insulin-dependent diabetes, anticoagulation therapy, or psychiatric medications should maintain a backup pharmacy relationship or at minimum understand Capsule's protocol for handling supply disruptions before committing all prescriptions to a single delivery service.

Questions to Ask Before Transferring

Before transferring your prescriptions to Capsule, ask the following directly through their app or pharmacist line:

  1. Does Capsule hold a valid pharmacy license in my state of residence?
  2. Can Capsule dispense my specific medications, including any Schedule II or specialty drugs?
  3. What is the protocol if a delivery fails or a medication is out of stock?
  4. Is there a licensed pharmacist available by phone or secure message during business hours?
  5. What is the process for reporting a dispensing error?

Getting clear answers to all five questions before transferring is a standard due-diligence step regardless of which pharmacy you use.


Independent Assessment: Legitimate but Not Fully Verified

Capsule operates as a licensed retail pharmacy and meets the basic legal requirements to dispense prescriptions in its licensed states. The prescription-requirement and pharmacist-oversight criteria that the FDA identifies as core legitimacy signals are present.

Where Capsule falls short relative to some competitors is in voluntary third-party verification. No current LegitScript certification, no NABP accreditation, and no URAC accreditation are publicly confirmed. For most patients filling common generic medications with insurance, this gap is unlikely to affect day-to-day safety. For patients filling specialty medications, controlled substances, or high-stakes chronic-disease therapies, the absence of independent ongoing monitoring is a meaningful data point.

The BBB complaint record reflects operational frustrations more than clinical danger, but delivery reliability is itself a safety concern when medication continuity is at stake.

Capsule is not on any FDA, NABP, or DEA list of problematic or rogue pharmacies. That is an important baseline. But "not flagged as dangerous" and "independently verified as safe" are different categories, and patients deserve to understand which one applies.


Frequently asked questions

Is Capsule pharmacy legit?
Yes, Capsule is a licensed retail pharmacy operating under state pharmacy board authorization. It meets the FDA's baseline criteria for a legitimate pharmacy: it requires valid prescriptions and employs licensed pharmacists. However, it does not currently hold LegitScript certification or NABP accreditation, which are voluntary but meaningful third-party safety verifications.
Does Capsule have LegitScript certification?
As of July 2025, Capsule does not appear in the public LegitScript pharmacy verification database. LegitScript certification is voluntary for U.S.-based retail pharmacies, so absence does not indicate illegal operation, but it does mean one layer of ongoing independent monitoring is missing.
Is Capsule NABP accredited?
No. Capsule does not currently appear in the NABP accredited pharmacy directory. NABP accreditation is a gold-standard voluntary credential that verifies a pharmacy meets state and federal dispensing and safety laws.
What complaints have been filed against Capsule?
Public BBB complaint records for Capsule show a pattern of delivery failures, insurance billing disputes, and communication gaps. Clinical dispensing errors appear less frequently in the public record. Patients should review the live BBB profile for current complaint volume and resolution rates.
Does Capsule accept insurance?
Yes. Capsule accepts most major insurance plans including those processed through CVS Caremark, Express Scripts, and OptumRx. Patients should confirm their specific plan is accepted before transferring prescriptions.
Can Capsule dispense controlled substances?
Capsule has reported limitations on dispensing Schedule II controlled substances such as amphetamine salts (Adderall) and methylphenidate (Ritalin). Patients requiring Schedule II medications should contact Capsule directly to confirm current policy before attempting a prescription transfer.
Is Capsule safe to use for chronic medications?
Capsule is generally safe for common generic chronic medications. Patients on high-stakes therapies (anticoagulants, insulin, specialty biologics) should maintain a backup pharmacy and confirm Capsule's specific dispensing capabilities and disruption protocols before relying on it as a sole pharmacy.
Who owns Capsule pharmacy now?
Amazon acquired Capsule in 2023 as part of its healthcare expansion, then divested it. As of mid-2025, Capsule operates as an independent company. Ownership changes can affect operational stability, which is one reason maintaining a backup pharmacy relationship is prudent during transition periods.
How does Capsule compare to Amazon Pharmacy?
Both are delivery pharmacies accepting insurance and cash pay. Amazon Pharmacy operates at larger national scale with more publicly disclosed state licensure documentation. Neither Amazon Pharmacy nor Capsule universally holds all available voluntary accreditations, but Amazon's size means greater regulatory visibility.
Does Capsule dispense GLP-1 medications like Ozempic or Wegovy?
Capsule dispenses commercially manufactured brand and generic medications when they are in supply. GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have faced persistent supply shortages. Patients should confirm availability directly with Capsule. Capsule does not appear to dispense FDA-registered compounded semaglutide.
What should I do if Capsule makes a dispensing error?
Document the error with photographs of the medication label and packaging, contact Capsule's pharmacist line immediately, file a report with your state pharmacy board, and report the error to the FDA MedWatch program at fda.gov/safety/medwatch. Reporting protects other patients.
How can I verify Capsule is licensed in my state?
Visit your state pharmacy board's public license lookup tool and search for Capsule by its registered business name or address. The NABP also maintains a database of state board websites at nabp.pharmacy. Capsule must hold a valid non-resident pharmacy license in your state to legally dispense prescriptions to you.

References

  1. Orizio G, Merla A, Schulz PJ, Gelatti U. Quality of online pharmacies and websites selling prescription drugs: a systematic review. J Med Internet Res. 2011;13(3):e74. PubMed PMID: 21771717.
  2. Fittler A, Bősze G, Botz L. Evaluating aspects of online medication safety in long-term follow-up of 136 Internet pharmacies. Interdiscip Toxicol. 2013;6(2):67-75. PubMed PMID: 24170987.
  3. Mackey TK, Liang BA, Attaran A, Kohler JC. Ensuring the safety of internet pharmacies: a systematic review. J Pharm Policy Pract. 2015;8(1):1. PubMed PMID: 28756019.
  4. Mojtabai R. Perceived reasons for and consequences of purchasing prescription drugs online without a prescription. J Pharm Policy Pract. 2018;11:30. PubMed PMID: 30338074.
  5. Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. JAMA. 2008;300(21):2514-2526. PubMed PMID: 19050195.
  6. Happe LE, Clark D, Holliday E, Young T. A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization. J Manag Care Spec Pharm. 2014;20(7):677-84. PubMed PMID: 24964727.
  7. Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009;15(7):457-64. PubMed PMID: 19589013.
  8. Corrao G, Zambon A, Parodi A, et al. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens. 2008;26(4):819-24. PubMed PMID: 18327089.
  9. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836-41. PubMed PMID: 17000939.
  10. Kim J, Hajjar ER, Dewulf BD, et al. Medication adherence in patients with chronic conditions. JAMA Intern Med. 2019;179(8):1097-1105. PubMed PMID: 30985871.
  11. U.S. Food and Drug Administration. BeSafeRx: Know Your Online Pharmacy. FDA.gov. Accessed July 2025.
  12. U.S. Food and Drug Administration. Quick Tips for Buying Medicines Over the Internet. FDA.gov. Accessed July 2025.
  13. National Association of Boards of Pharmacy. NABP Pharmacy Accreditation Program. Nabp.pharmacy. Accessed July 2025.
  14. Osei-Bonsu E, Kline MA, Sorofman B, Reist JC. Characteristics and safety of online pharmacies. J Am Pharm Assoc. 2021;61(2):e44-e52. PubMed PMID: 33423917.